EUVIMEDEUVIMED entdecken
Crossref

Unmasking Biofilm Associated Antimicrobial Resistance in Pseudomonas Aerugionosa: Insights from a Tertiary Care Hospital in Northern India

Mudhita Mahajan, Usra Jawaid, Sonal Jindal, Molly Madan

International Journal of Current Pharmaceutical Review and Research · 13.05.2026 · 18 (05)

DOI: 10.25258/ijcpr.18.5.2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 13.05.2026. Verfasst von Mudhita Mahajan und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pseudomonas aeruginosa is an opportunistic gram-negative bacillus with intrinsic and acquired resistance mechanisms, making it a major pathogen in both community and healthcare settings. Biofilm production further enhances its persistence, resistance to antimicrobials, and ability to cause chronic or recurrent infections. Surveillance of local antimicrobial susceptibility trends, especially in healthcare centres, is essential for guiding empirical therapy and infection control. Aim and Objectives: To determine prevalence of P. aeruginosa isolates from all the clinical samples in a tertiary care hospital and to correlate between biofilm formation and antimicrobial resistance for these isolates.

Methods

This study was carried out at the Department of Microbiology of Al-Falah School of Medical Sciences, Faridabad associated with tertiary care hospital for a period of one year (January to December 2024). Out of total 4040 clinical samples processed, 82 isolates of P. aeruginosa identified using standard culture and biochemical tests. Biofilm detection done using Congo Red Agar (CRA) method and Microtiter Plate Assay (MPA). Conventional Antimicrobial susceptibility testing (AST) was performed using Mueller–Hinton agar Kirby–Bauer disc diffusion method as per CLSI 2025 guidelines. Statistical analysis was done using SPSS version 26.

Results

Out of total 82 Pseudomonas isolates, 46 (56.1%) were from male patients and 36 (43.9%) from female patients. Outpatient isolates (72.0%) outnumbered inpatient isolates (28.0%). Maximum isolates were from ear pus (38; 46.3%), followed by sputum (25; 30.5%), pus (10; 12.2%), urine (3; 3.7%), blood (3; 3.7%), and conjunctival swabs (3; 3.7%). Biofilm assays revealed 34 strong (41.5%), 22 moderate (26.8%), 16 weak (19.5%) producers, and 10 are non-biofilm producers (12.2%). Piperacillin–tazobactam demonstrated the lowest resistance (3.7%), while imipenem exhibited the highest (56.1%). Strong biofilm producers showed significantly higher resistance to all tested antibiotics was statistically significant (p

Zitieren

APA

Mahajan, M., Jawaid, U., Jindal, S., & Madan, M. (2026). Unmasking Biofilm Associated Antimicrobial Resistance in Pseudomonas Aerugionosa: Insights from a Tertiary Care Hospital in Northern India. International Journal of Current Pharmaceutical Review and Research, 18(05). https://doi.org/10.25258/ijcpr.18.5.2

Vancouver

Mahajan M, Jawaid U, Jindal S, Madan M. Unmasking Biofilm Associated Antimicrobial Resistance in Pseudomonas Aerugionosa: Insights from a Tertiary Care Hospital in Northern India. International Journal of Current Pharmaceutical Review and Research. 2026;18(05). doi:10.25258/ijcpr.18.5.2

BibTeX
@article{Mahajan2026,
  author = {Mahajan, Mudhita and Jawaid, Usra and Jindal, Sonal and Madan, Molly},
  title = {Unmasking Biofilm Associated Antimicrobial Resistance in Pseudomonas Aerugionosa: Insights from a Tertiary Care Hospital in Northern India},
  journal = {International Journal of Current Pharmaceutical Review and Research},
  year = {2026},
  volume = {18},
  number = {05},
  doi = {10.25258/ijcpr.18.5.2}
}
Kostenlos starten →